Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9278)
All Articles published online
|
Jan 14, 2012 (publication date) through Jul 12, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsianos EV, Katsanos KH, Tsianos VE. Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol 2012; 18(2): 105-118 [PMID: 22253516 DOI: 10.3748/wjg.v18.i2.105] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i2/105.htm |
| Number | Citing Articles |
| 1 |
Tao Jiang, Beibei Qin, Jianqin He, Shuangyan Lin, Shiping Ding. Three isoforms of the Atg16L1 protein contribute different autophagic properties. Molecular and Cellular Biochemistry 2013; 378(1-2): 257 doi: 10.1007/s11010-013-1616-8
|
| 2 |
Yu Wen Li, Ci Qiu Yang, Ying Lian Xiao, Jie Li, Chen Xi Xie, Sheng Hong Zhang, Qiao Yu, Hui Ling Wang, Wei Ming Lu, Min Hu Chen. The ‐A2518G polymorphism in the MCP‐1 gene and inflammatory bowel disease risk: A meta‐analysis. Journal of Digestive Diseases 2015; 16(4): 177 doi: 10.1111/1751-2980.12232
|
| 3 |
Vahab Alamdari-Palangi, Farzaneh Vahedi, Zahra Shabaninejad, Sadat Dokeneheifard, Ahmad Movehedpour, Mortaza Taheri-Anganeh, Amir Savardashtaki. microRNA in inflammatory bowel disease at a glance. European Journal of Gastroenterology & Hepatology 2021; 32(2): 140 doi: 10.1097/MEG.0000000000001815
|
| 4 |
Mario García-Domínguez. Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic Perspectives. Biomolecules 2024; 14(8): 926 doi: 10.3390/biom14080926
|
| 5 |
Iván Igaz, Mihály Szőnyi, Patrícia Varga, Lajos Topa. Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases. Orvosi Hetilap 2014; 155(13): 487 doi: 10.1556/OH.2014.29864
|
| 6 |
Faizan Alawi. An Update on Granulomatous Diseases of the Oral Tissues. Dental Clinics of North America 2013; 57(4): 657 doi: 10.1016/j.cden.2013.07.004
|
| 7 |
Erica Chang, Caroline Chinchilla Putzeys, Edward Hoffenberg, Ashish Patel, Elizabeth Hilow, Brad Pasternak. Genital Crohn's disease in pediatrics and genetic associations. JPGN Reports 2025; doi: 10.1002/jpr3.70022
|
| 8 |
Irene Fung, Jackie P.-D. Garrett, Anupama Shahane, Mildred Kwan. Do Bugs Control Our Fate? The Influence of the Microbiome on Autoimmunity. Current Allergy and Asthma Reports 2012; 12(6): 511 doi: 10.1007/s11882-012-0291-2
|
| 9 |
Marianne R. Spalinger, Silvia Lang, Achim Weber, Pascal Frei, Michael Fried, Gerhard Rogler, Michael Scharl. Loss of Protein Tyrosine Phosphatase Nonreceptor Type 22 Regulates Interferon-γ–Induced Signaling in Human Monocytes. Gastroenterology 2013; 144(5): 978 doi: 10.1053/j.gastro.2013.01.048
|
| 10 |
Beatrice E Torere, Henry O Aiwuyo, Jennifer L Kennard. Leukocytoclastic Vasculitis and Myositis as Initial Manifestations of Crohn’s Disease. Cureus 2022; doi: 10.7759/cureus.33127
|
| 11 |
Mohammad Salem, Jakob Benedict Seidelin, Gerhard Rogler, Ole Haagen Nielsen. Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyond. Cellular and Molecular Life Sciences 2013; 70(18): 3391 doi: 10.1007/s00018-012-1246-4
|
| 12 |
Anna Duda-Madej, Jakub Stecko, Natalia Szymańska, Agnieszka Miętkiewicz, Marta Szandruk-Bender. Amyloid, Crohn’s disease, and Alzheimer’s disease - are they linked?. Frontiers in Cellular and Infection Microbiology 2024; 14 doi: 10.3389/fcimb.2024.1393809
|
| 13 |
Dipanwita Kapoor, Kathy Teahon, Suzanne VF Wallace. Inflammatory bowel disease in pregnancy. The Obstetrician & Gynaecologist 2016; 18(3): 205 doi: 10.1111/tog.12271
|
| 14 |
Pedro Gonçalves, Fernando Magro, Fátima Martel. Metabolic Inflammation in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(2): 453 doi: 10.1097/MIB.0000000000000209
|
| 15 |
Jin Soo Moon. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatric Gastroenterology, Hepatology & Nutrition 2019; 22(1): 50 doi: 10.5223/pghn.2019.22.1.50
|
| 16 |
Ria Margiana, Hamzah H. Kzar, Fadhil Hussam, Noora M. Hameed, Zahraa Haleem Al-qaim, Moaed E. Al-Gazally, Mahmoud Kandee, Marwan Mahmood Saleh, Bobur Bakhrom ugli Toshbekov, Farkhod Tursunbaev, Sajad Karampoor, Rasoul Mirzaei. Exploring the impact of miR-128 in inflammatory diseases: A comprehensive study on autoimmune diseases. Pathology - Research and Practice 2023; 248: 154705 doi: 10.1016/j.prp.2023.154705
|
| 17 |
Raquel Franco Leal, Marciane Milanski, Cláudio Saddy Rodrigues Coy, Mariana Portovedo, Viviane Soares Rodrigues, Andressa Coope, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Lício Augusto Velloso. Autophagy and proinflammatory cytokine expression in the intestinal mucosa and mesenteric fat tissue of patients with Crohn's disease. Journal of Coloproctology 2013; 33(01): 009 doi: 10.1016/j.jcol.2012.10.001
|
| 18 |
ManzoorA Malik. MDR1C3435T polymorphism and inflammatory bowel disease. Saudi Journal of Gastroenterology 2015; 21(2): 121 doi: 10.4103/1319-3767.153843
|
| 19 |
Aysegul Sagir Kahraman. Editorial for “Novel Associations Between Genome‐Wide Single Nucleotide Polymorphisms and MR Enterograpy Features in Crohn's Disease Patients”. Journal of Magnetic Resonance Imaging 2021; 53(1): 139 doi: 10.1002/jmri.27356
|
| 20 |
Jixiang Zhang, Jianhong Wu, Xiulan Peng, Jia Song, Jun Wang, Weiguo Dong, Georgina L. Hold. Associations between STAT3 rs744166 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-Analysis. PLoS ONE 2014; 9(10): e109625 doi: 10.1371/journal.pone.0109625
|
| 21 |
Sanjana Vijay Nemade, Kiran Jaywant Shinde. Granulomatous diseases in Otorhinolaryngology, Head and Neck. 2021; : 207 doi: 10.1007/978-981-16-4047-6_23
|
| 22 |
Xiaolei Wang, Li Qin, Jingli Cao, Jing Zhao. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn’s disease: a systematic review and meta-analysis. Current Medical Research and Opinion 2016; 32(12): 2007 doi: 10.1080/03007995.2016.1226168
|
| 23 |
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2019; 2019(11) doi: 10.1002/14651858.CD012878.pub2
|
| 24 |
Sanja Dragasevic, Biljana Stankovic, Tomica Milosavljevic, Aleksandra Sokic-Milutinovic, Snezana Lukic, Tamara Alempijevic, Branka Zukic, Nikola Kotur, Gordana Nikcevic, Sonja Pavlovic, Dragan Popovic. Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2017; 29(8): 909 doi: 10.1097/MEG.0000000000000877
|
| 25 |
Matthew A. Croxen, Robyn J. Law, Roland Scholz, Kristie M. Keeney, Marta Wlodarska, B. Brett Finlay. Recent Advances in Understanding Enteric Pathogenic Escherichia coli. Clinical Microbiology Reviews 2013; 26(4): 822 doi: 10.1128/CMR.00022-13
|
| 26 |
Mohamad Abbass, Jeremy Cepek, Claire E Parker, Tran M Nguyen, John K MacDonald, Brian G Feagan, Reena Khanna, Vipul Jairath. Adalimumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2017; doi: 10.1002/14651858.CD012878
|
| 27 |
Yongchun Shen, Shujin Guo, Ting Yang, Liuqun Jia, Lei Chen, Jing An, Tao Wang, Fuqiang Wen. The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis. International Journal of Molecular Sciences 2013; 14(6): 11392 doi: 10.3390/ijms140611392
|
| 28 |
Naif Alenazi, Hesham Alsaeed, Adel Alsulami, Turki Alanzi. A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease. International Journal of General Medicine 2021; : 7099 doi: 10.2147/IJGM.S336678
|
| 29 |
Bruno Lorenzo SCOLARO, Emily dos SANTOS, Leslie Ecker FERREIRA, Paulo Henrique Condeixa de FRANÇA, Harry KLEINUBING, Paulo Gustavo KOTZE, Mauro de Souza Leite PINHO. T300A GENETIC POLYMORPHISM: a susceptibility factor for Crohn’s disease?. Arquivos de Gastroenterologia 2014; 51(2): 97 doi: 10.1590/S0004-28032014000200005
|
| 30 |
Mingwei Zhang, Tian Qiu, Wenbing Yang, Zhipeng Zhang, Bokai Shi. Bi-omics prognostic model for invasive ductal carcinoma using deep learning. Proceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science 2023; : 682 doi: 10.1145/3644116.3644229
|
| 31 |
Raquel F. Leal, Francesca A. Ramos Silva. Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging. 2017; : 313 doi: 10.1016/B978-0-12-812146-7.00014-7
|
| 32 |
Ahmed H. Al-Salem. Anal and Perianal Conditions in Children. 2025; : 185 doi: 10.1007/978-3-031-87001-9_9
|
| 33 |
Cinthia Cruz‐Romero, Abra Guo, William F. Bradley, Joao R.T. Vicentini, Vijay Yajnik, Michael S. Gee. Novel Associations Between Genome‐Wide Single Nucleotide Polymorphisms and MR Enterography Features in Crohn's Disease Patients. Journal of Magnetic Resonance Imaging 2021; 53(1): 132 doi: 10.1002/jmri.27250
|
| 34 |
|
| 35 |
Diana Lacruz-Guzmán, Daniel Torres-Moreno, Francisco Pedrero, Patricia Romero-Cara, Iván García-Tercero, Javier Trujillo-Santos, Pablo Conesa-Zamora. Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitis. European Journal of Clinical Pharmacology 2013; 69(3): 431 doi: 10.1007/s00228-012-1389-0
|
| 36 |
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson, Bruce E Sands. ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 2018; 113(4): 481 doi: 10.1038/ajg.2018.27
|
| 37 |
Eiichi Momotani, Hiroshi Ozaki, Masatoshi Hori, Shizuo Yamamoto, Takashi Kuribayashi, Shigetoshi Eda, Masahiro Ikegami. Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn’s disease-type necrotizing colitis in Mice. SpringerPlus 2012; 1(1) doi: 10.1186/2193-1801-1-47
|
| 38 |
Jin Soo Moon. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intestinal Research 2019; 17(1): 17 doi: 10.5217/ir.2018.00139
|
| 39 |
Ivana Kern, Olaf Schoffer, Thomas Richter, Wieland Kiess, Gunter Flemming, Ulf Winkler, Jürgen Quietzsch, Olaf Wenzel, Marlen Zurek, Ulf Manuwald, Janice Hegewald, Shi Li, Jens Weidner, Jan de Laffolie, Klaus-Peter Zimmer, Joachim Kugler, Martin W. Laass, Ulrike Rothe, Mathilde Body-Malapel. Current and projected incidence trends of pediatric-onset inflammatory bowel disease in Germany based on the Saxon Pediatric IBD Registry 2000–2014 –a 15-year evaluation of trends. PLOS ONE 2022; 17(9): e0274117 doi: 10.1371/journal.pone.0274117
|
| 40 |
Anna Monica Bianco, Valentina Zanin, Lorenzo Monasta, Stefano Martelossi, Annalisa Marcuzzi, Sergio Crovella. Family history in early-onset inflammatory bowel disease. Journal of Gastroenterology 2013; 48(1): 144 doi: 10.1007/s00535-012-0654-4
|
| 41 |
Plamen K. Krastev, Alexander B. Blazhev, Galya Ts. Stavreva. Effect of Aminosteroid U74389G in a Model of Inflammatory Bowel Disease in Rats. Journal of Biomedical and Clinical Research 2021; 14(2): 131 doi: 10.2478/jbcr-2021-0018
|
| 42 |
Seana ML Nelson, Tran M Nguyen, John WD McDonald, John K MacDonald. Natalizumab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2018; 2018(8) doi: 10.1002/14651858.CD006097.pub3
|
| 43 |
Ji-Xiang Zhang, Jia Song, Jun Wang, Wei-Guo Dong. JAK2 rs10758669 Polymorphisms and Susceptibility to Ulcerative Colitis and Crohn's Disease: A Meta-analysis. Inflammation 2014; 37(3): 793 doi: 10.1007/s10753-013-9798-5
|